Theranostics: Paintball targeting of cancer cells combined with precision therapySeptember 13, 2017
RESTON, Va. - The Journal of Nuclear Medicine's September 2017 supplement shines a spotlight on theranostics and its increasingly important role in the delivery of precision medicine. Theranostics refers to the combination of a predictive biomarker, identified through diagnostic imaging using radiolabeled ligands (which lock onto the specific cancer cell receptor/biomarker), with precise therapy targeted on the now-marked cancer cells. The cancer cells are destroyed, while healthy cells are unharmed -- minimizing side effects and improving quality of life for patients.
"Theranostics is the future of precision medicine," explains Wolfgang A. Weber, MD, chief of the Molecular Imaging and Therapy Service at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. "Therapies are not selected based on genetic mutations that may or may not be present in all cancer cells, but on imaging the whole patient and determining if a specific treatment can be effective. Because of the specific targeting of the cancer cells, theranostic agents are extremely well tolerated."
This JNM Supplement on Clinical and Translational Theranostics is edited by Ken Herrmann, MD, MBA, chair of nuclear medicine at the University of Duisburg-Essen, Essen, Germany, and Steven M. Larson, MD, and Weber, both at MSKCC. Their introductory article points out that theranostics is "more than just a fashion trend." It notes that "the idea of using a radioactive compound for diagnostic imaging, target-expression confirmation, and radionuclide therapy dates back to 1946, when Seidlin et al. published the first study on radioiodine therapy for metastatic thyroid cancer. More recently, sodium-iodine-124 and sodium-iodine-131 (Na124I/Na131I) have become important for thyroid cancer monitoring.
Today, Herrmann says, "The theranostic concept has gained new momentum with the recent success of peptide receptor radioligand therapy (PRRT) in neuroendocrine tumors (NETs)." He adds, "The current expansion of this concept to prostate cancer targeting the prostate specific membrane antigen (PSMA) is bringing theranostics to another level. Both are already in clinical use, with PRRT for NETs awaiting FDA approval at any moment."
Articles in the JNM supplement cover research on multireceptor targeting and new strategies for both PSMA imaging/therapy and targeting the somatostatin receptor (so effectively used in PRRT for NETs), as well as exciting research on theranostics for other cancers, including intraarterial yttrium-90 (90Y) therapy for liver metastases. Herrmann points out, "Additional promising theranostic research includes targeting the CXCR4-receptor in hematooncological tumors, the neurotensin 1 receptor in pancreatic cancer, Ewing sarcoma and gastrointestinal tumors, as well as alpha-MSH1 [alpha-melanocyte-stimulating hormone 1] in melanoma."
For nuclear medicine, Weber says, "Theranostics will be practice-changing. Right now, nuclear medicine is dominated by hybrid imaging (PET/CT, SPECT/CT). Theranostics will bring therapy and patient care to the center of nuclear medicine. In other words, the field will change from 'nuclear radiology' to true 'nuclear medicine.'"
Weber emphasizes, "The most important future development is to combine theranostics with other cancer therapies and use theranostics earlier in the course of disease in order to achieve not only prolongation of survival, but cures."
As Herrmann notes, "This is just the beginning of the era of theranostics!"
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.
SNMMI's more than 15,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit http://www.snmmi.org.
Society of Nuclear Medicine
Related Cancer Cells Articles:
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
A gene previously identified as critical for tumor growth in many human cancers also maintains intestinal stem cells and encourages the growth of cells that support them, according to results of a study led by Johns Hopkins researchers.
Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem.
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body's immune response to fight cancer.
Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.
Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers.
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Related Cancer Cells Reading:
One Renegade Cell: How Cancer Begins (Science Masters Series)
by Robert A. Weinberg (Author)
Cancer research has reached a major turning point, and no one is better qualified to explain the past two deacades' dramatic leaps forward in understanding this disease than world-renowned molecular biologist Robert Weinberg, director of the Oncology Research Laboratory at the Whitehead Institute in Cambridge, Massachusetts. In One Renegade Cell, Weinberg presents a state-of-the-art account of how cancer begins and how, one day, it will be cured. View Details
NCCN Guidelines for Patients®: Lung Cancer (Non-Small Cell), Version 1.2016
by National Comprehensive Cancer Network® (NCCN®) (Author)
[OFFICIAL CURRENT VERSION] From the medical leaders of 27 of the world’s most renowned cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to lung cancer (non-small cell lung cancer). Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources about the diagnosis and treatment of lung cancer. Each patient-friendly chapter prepares patients and caregivers to talk with their... View Details
How To Kill Cancer Cells: Make Your Body Healthy Now
by Natalie Mitchell (Author)
Natalie Mitchell’s Amazon Best Seller second book “How To Kill Cancer Cells” sets out clear guidelines for readers to create a bodily environment in which cancer cells cannot thrive. Everybody has cancer cells and with the medical technology available nowadays doctors can only diagnose cancer disease when people already have developed BILLIONS of active cancer cells in their body. While the information itself is easy to understand, the Author’s clear message is that we, as individuals, can control our susceptibility to Cancer, eliminate Cancer cells and prevent and avoid the disease... View Details
Cancer: The Outlaw Cell
by Richard LaFond (Editor)
We live in an era in which scientific information grows by the day and is so specialized that no one person can possibly absorb and kept abreast of the literature. Substantial developments in science and medicine, powered by developing technologies such as genetic sequencing, proteomics, and nanobiology, have driven cancer research forward, and a review of where we are now is desperately needed.
Cancer: The Outlaw Cell is a collection of twenty-five focused chapters written by leading researchers at the forefront of cancer research. Authors present the current state of... View Details
Small Cell Lung Cancer - Treatment Options and Alternative Medicine
by Christian Vazquez (Author)
Small Cell Lung Cancer is a full crash course on the topic. We reviewed over 300 of the strongest natural agents that exist for cancer and found only 6 that have conclusive evidence for small cell lung cancer. The biggest problem is not lack of information in the world, it is the lack of time, understanding of the medical data associated with scientific research and to top it off there is so much data in so many directions between the pharmaceutical, people trying to steer you in the wrong way to make a quick dollar, the quacks of the industry and everything else imaginable where at the end... View Details
Essential Oils And Cancer: How To Effectively Use The Right Essential Oils To Confuse And Kill Cancer Cells
by Nancy Dennett Ducharme (Author)
Essential oils have been used for centuries to help support the immune system and bring the body back to health. This first book in the Essential Oils And Cancer series shows step by step exactly how to use essential oils to fight cancer. Learn how to prepare and use the compounds in two specific plant species to attack and destroy abnormal cells and cell mutations that have grown out of control. Learn which combinations of essential oils to use with breast cancer, bone cancer, lung cancer, skin cancer, prostate cancer, and other cancers according to latest scientific research. View Details
The Cancer Fighting Diet: Diet and Nutrition Strategies to Help Weaken Cancer Cells and Improve Treatment Results
by Dr. Johannes Coy Sc.D. (Author), Maren Franz (Author)
This book provides basic information about cancer, as well as detailed advice and a comprehensive diet plan to help fight a personal battle with cancer and significantly improve chances of a cure.
There are complex processes inside the human body and specific mechanisms that can lead to the development and spread of cancer cells. Understanding the causes for what is happening inside the body is the key to implementing the recommendations in this guide.
Using these recipes and nutritional strategies will cut dramatically down on sugar in order to deplete the strength and... View Details
Cell War Notebooks: My Journey with Cervical Cancer
by Julie Forward DeMay (Author)
Beautifully written, heartwarming, and passionate, Cell War Notebooks draws us into a world many are familiar with. Recorded as a blog during a period of seven months, Cell War Notebooks is both a sensitive and brutally honest account of life with cancer. An essential read for people coping with the disease, and for the family and friends who support and love them, it's the deeply motivating story of a battle Julie Forward DeMay is determined to win. One of few memoirs written about cervical cancer, her inspirational journey was published for many reasons, one of which was to create a general... View Details
The Immortal Life of Henrietta Lacks
by Rebecca Skloot (Author)
Now an HBO® Film starring Oprah Winfrey and Rose Byrne
#1 NEW YORK TIMES BESTSELLER
Her name was Henrietta Lacks, but scientists know her as HeLa. She was a poor black tobacco farmer whose cells—taken without her knowledge in 1951—became one of the most important tools in medicine, vital for developing the polio vaccine, cloning, gene mapping, and more. Henrietta's cells have been bought and sold by the billions, yet she remains virtually unknown, and her family can't afford health insurance. This phenomenal New York Times bestseller tells a riveting story... View Details
Fast Facts: Non-Small-Cell Lung Cancer
by Mary O'Brien (Author), Benjamin Besse (Author)
Rapid developments in the classification, screening and treatment of non-small-cell lung cancer (NSCLC) are improving outcomes for patients with the disease. This insightful guide is designed to bring you up to speed with recent advances, including: - the latest CT-based screening and interval growth imaging techniques - proposed changes to the TNM classification system - the increasing trend for minimally invasive and lung-sparing surgery - stereotactic radiation for early-stage tumors - new targeted therapies - breakthroughs in personalized medicine. Today's developments will change... View Details